UNSPSC 51283922: Sulfathiourea

This classification denotes a sulfonamide anti-infective agent with the molecular formula C7H9N3O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MXF9G4I1V5, chemically known as urea, 1-sulfanilyl-2-thio- but generally known as sulfathiourea, which bears US NIH Compound Identifier 3000579. European Medicines Agency schedules Sulfathiourea in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10732MIG. The term SULFATHIOUREA is an International Non-Proprietary Name.

UNSPSC 51283922 Sulfathiourea, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code has generated no recent opportunities directly soliciting sulfathiourea or related chemical compounds; the four recent opportunities posted between January and July 2026 cover naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), medical and first aid supplies for emergency response (City of Tampa), and generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations reference sulfathiourea or industrial chemical procurement.

The recent opportunities solicited under this code tag span health and human services agencies—county health departments, state HHS commissions, municipal fire departments, and multistate cooperative purchasing alliances—rather than procurement of industrial or pharmaceutical precursor chemicals. The geographic spread covers Florida, Texas, Minnesota, and Oregon through cooperative purchasing, reflecting a scattered mix of issuing bodies with no concentration in any single jurisdiction or procurement class. Absent substantive recent activity directly related to sulfathiourea procurement, the code presents minimal decision relevance for business development targeting state and local opportunities in this commodity category. Firms pursuing contracts under this code should monitor whether future health-services or pharmaceutical-supply opportunities are mislabeled or whether sulfathiourea demand emerges in a different procurement category.